Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.36 USD | -1.48% | -3.77% | -15.49% |
May. 16 | Everlasting momentum | |
May. 16 | Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.49% | 87.9B | |
+34.35% | 705B | |
+28.94% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.11% | 238B | |
-3.03% | 210B | |
+10.02% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol-Myers Squibb, RayzeBio Say Hart-Scott-Rodino Act Waiting Period Expires